Tue, Sep 2, 2014, 8:07 AM EDT - U.S. Markets open in 1 hr 23 mins


% | $
Quotes you view appear here for quick access.

Intel Corporation Message Board

liljakr 2 posts  |  Last Activity: Aug 19, 2014 4:37 PM Member since: Jun 9, 2003
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Anyone have info on this news break?

    by an41466 Aug 19, 2014 4:20 PM
    liljakr liljakr Aug 19, 2014 4:37 PM Flag

    This is what is says:

    Achillion Pharma (NASDAQ: ACHN) announced that the U.S. Patent & Trademark Office has granted Achillion U.S. Patent No. 8,809,313, covering composition-of-matter and method of use claims for ACH-3102 and structurally related NS5A inhibitor compounds. ACH-3102 is Achillion's second generation Phase 2 NS5A inhibitor being investigated for the treatment of chronic hepatitis C virus (HCV) infection. This patent is entitled "Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections," and provides a patent term which lasts until 2032.

    You can see in there the wording about "being investigated", I am a little surprised that it is being put forward in a bullet point in a negative way, maybe not a well worded news article.

    Sentiment: Strong Buy

  • liljakr by liljakr Jun 20, 2014 11:32 AM Flag

    It is in the interest of the MM to keep ACHN in check as close to 8.25 as possible so they dont need to pay up. If that is the case then Monday should be interesting.

34.92+0.02(+0.06%)Aug 29 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Conns Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT